Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0015000LC2
Wed, 26.04.2023
Mainz BioMed N.V.
Mainz Biomed Announces Partnership with the Instituto de Microecologia to Expand ColoAlert® Commercialization in Spain and Portugal
The Instituto de Microecologia to market at-home detection test for colorectal cancer to physicians and their patients.
BERKELEY, US – MAINZ, Germany – April 26, 2023 — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed [ … ]
Wed, 26.04.2023
Mainz BioMed N.V.
Mainz Biomed Announces Partnership with the Instituto de Microecologia to Expand ColoAlert® Commercialization in Spain and Portugal
The Instituto de Microecologia to market at-home detection test for colorectal cancer to physicians and their patients.
BERKELEY, US – MAINZ, Germany – April 26, 2023 — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed [ … ]
Mon, 10.04.2023
Mainz BioMed N.V.
Mainz Biomed Provides Full Year 2022 Financial Results
ColoAlert Revenue Increases 130% Year over YearYear End Cash Balance of $17.1 Million
BERKELEY, US – MAINZ, Germany – April 10, 2023 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, a [ … ]
Mon, 10.04.2023
Mainz BioMed N.V.
Mainz Biomed Provides Full Year 2022 Financial Results
ColoAlert Revenue Increases 130% Year over YearYear End Cash Balance of $17.1 Million
BERKELEY, US – MAINZ, Germany – April 10, 2023 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, a [ … ]
Tue, 04.04.2023
Mainz BioMed N.V.
Mainz Biomed Expands Corporate Health Program for ColoAlert with the Addition of Three New Companies in Germany
BERKELEY, US – MAINZ, Germany – April 4, 2023 — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that three German-bas [ … ]
Tue, 04.04.2023
Mainz BioMed N.V.
Mainz Biomed Expands Corporate Health Program for ColoAlert with the Addition of Three New Companies in Germany
BERKELEY, US – MAINZ, Germany – April 4, 2023 — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that three German-bas [ … ]
Wed, 29.03.2023
Mainz BioMed N.V.
Mainz Biomed Reports Positive Results from Feasibility Study Evaluating its Portfolio of Novel mRNA Biomarkers for Early Detection of Advanced Colorectal Adenomas
Mainz Biomed’s proprietary nucleic acid extraction and PCR process proved to be highly effective
Two mRNA biomarkers found to be particularly valuable in detecting disease signals in ad [ … ]
Wed, 29.03.2023
Mainz BioMed N.V.
Mainz Biomed Reports Positive Results from Feasibility Study Evaluating its Portfolio of Novel mRNA Biomarkers for Early Detection of Advanced Colorectal Adenomas
Mainz Biomed’s proprietary nucleic acid extraction and PCR process proved to be highly effective
Two mRNA biomarkers found to be particularly valuable in detecting disease signals in ad [ … ]
Tue, 21.03.2023
Mainz BioMed N.V.
Mainz Biomed to Present at Sidoti Virtual Investor Conference March 22-23
BERKELEY, US – MAINZ, Germany – March 21, 2023 — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced that Bill Caragol, the Company’s CFO, will present and host one [ … ]
Tue, 21.03.2023
Mainz BioMed N.V.
Mainz Biomed to Present at Sidoti Virtual Investor Conference March 22-23
BERKELEY, US – MAINZ, Germany – March 21, 2023 — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced that Bill Caragol, the Company’s CFO, will present and host one [ … ]